Michael Sharpe

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 20:17, May 7, 2018 by Kmdenmark (talk | contribs) (removed abstracts; moved Quotations to Discussion page)
Michael-sharpe.jpg

Professor Michael Sharpe, M.A., M.R.C.P., M.R.C.Psych., is a British professor of psychological medicine at the University of Oxford, in the United Kingdom. He is a key author of the PACE trial helping to devise the Oxford criteria as a diagnostic tool for Chronic Fatigue Syndrome.

Notable studies[edit | edit source]

Books[edit | edit source]

Media coverage and interviews[edit | edit source]

Online presence[edit | edit source]

List of publications[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Sharpe, M; Chalder, T; Johnson, AL; Goldsmith; White, PD (2017), "Response to: Do more people recover from chronic fatigue syndrome with cognitive behaviour therapy or graded exercise therapy than with other treatments?", Fatigue: Biomedicine, Health & Behavior, 5 (1), doi:10.1080/21641846.2017.1288629
  2. Schröder, Andreas; Ørnbøl, Eva; Jensen, Jens S.; Sharpe, Michael; Fink, Per (2017), "Long-term economic evaluation of cognitive-behavioural group treatment versus enhanced usual care for functional somatic syndromes", Journal of Psychosomatic Research, doi:10.1016/j.jpsychores.2017.01.005
  3. Sharpe, M; Chalder, T; Palmer, I; Wessely, S (1997), "Chronic fatigue syndrome. A practical guide to assessment and management" (PDF), Gen Hosp Psychiatry, 19 (3): 185-99, doi:10.1016/S0163-8343(97)80315-5, PMID 9218987